The Crohn's and Colitis Foundation enters partnership with LifeArc to develop first clinical tests to predict disease course and response to treatment in pediatric Crohn's patients.
NEW YORK, NY– The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer Inc., has announced the results of a request for proposal (RFP) to reduce health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD).
The American College of Gastroenterology (ACG) and The Crohn’s & Colitis Foundation (the Foundation) are proud to announce their joint publication of “Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States” in both
After serving 4 years as co-Editor of the journal Fabio Cominelli, MD, PhD, has been named Editor-in-Chief and Sonia Friedman, MD, FACG, who is joining the editorial leadership, has been named Deputy Editor.
Washington, D.C. - Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule.
NEW YORK, NY – Today, 48 national health organizations sent a letter to members of Congress urging them to fund critical education about COVID-19 and cancelled research activities as a result of the pandemic.
The Crohn’s & Colitis Foundation (the Foundation) is pleased to announce five new members of its National Board of Trustees, which oversees the management of the organization’s policies, practices, principles, affairs, funds, and property.